EFFECT OF EXTRA-FINE TRIPLE THERAPY WITH BECOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRRONIUM BROMIDE (BDP/FF/GB) PRESSURIZED METERED DOSE INHALER (PMDI) ON EXACERBATIONS IN EAST ASIAN PATIENTS WITH COPD: THE TRIVERSYTI STUDY